These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26987557)

  • 1. Normative NeuroFlexor data for detection of spasticity after stroke: a cross-sectional study.
    Pennati GV; Plantin J; Borg J; Lindberg PG
    J Neuroeng Rehabil; 2016 Mar; 13():30. PubMed ID: 26987557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying neural and non-neural components of wrist hyper-resistance after stroke: Comparing two instrumented assessment methods.
    Andringa A; Meskers C; van de Port I; Zandvliet S; Scholte L; de Groot J; Kwakkel G; van Wegen E
    Med Eng Phys; 2021 Dec; 98():57-64. PubMed ID: 34848039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity, Intra-Rater Reliability and Normative Data of the Neuroflexor™ Device to Measure Spasticity of the Ankle Plantar Flexors after Stroke.
    Pennati GV; Carment L; Godbolt AK; Plantin J; Borg J; Lindberg PG
    J Rehabil Med; 2023 Mar; 55():jrm00356. PubMed ID: 36867093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest and inter-rater reliability of a method to measure wrist and finger spasticity.
    Gäverth J; Sandgren M; Lindberg PG; Forssberg H; Eliasson AC
    J Rehabil Med; 2013 Jul; 45(7):630-6. PubMed ID: 23695917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of the NeuroFlexor method to measure change in spasticity after treatment with botulinum toxin A in wrist and finger muscles.
    Gäverth J; Eliasson AC; Kullander K; Borg J; Lindberg PG; Forssberg H
    J Rehabil Med; 2014 Jul; 46(7):629-34. PubMed ID: 24850135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement Properties of the NeuroFlexor Device for Quantifying Neural and Non-neural Components of Wrist Hyper-Resistance in Chronic Stroke.
    Andringa A; van Wegen E; van de Port I; Kwakkel G; Meskers C
    Front Neurol; 2019; 10():730. PubMed ID: 31379705
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomechanical measurement of post-stroke spasticity.
    Kumar RT; Pandyan AD; Sharma AK
    Age Ageing; 2006 Jul; 35(4):371-5. PubMed ID: 16675479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cut-off score of the modified Ashworth scale corresponding to walking ability and functional mobility in individuals with chronic stroke.
    Freire B; Bochehin do Valle M; Lanferdini FJ; Foschi CVS; Abou L; Pietta-Dias C
    Disabil Rehabil; 2023 Mar; 45(5):866-870. PubMed ID: 35171052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural and nonneural contributions to wrist rigidity in Parkinson's disease: an explorative study using the NeuroFlexor.
    Zetterberg H; Frykberg GE; Gäverth J; Lindberg PG
    Biomed Res Int; 2015; 2015():276182. PubMed ID: 25685778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements in spasticity and motor function using a static stretching device for people with chronic hemiparesis following stroke.
    Jo HM; Song JC; Jang SH
    NeuroRehabilitation; 2013; 32(2):369-75. PubMed ID: 23535801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
    Lee HM; Chen JJ; Wu YN; Wang YL; Huang SC; Piotrkiewicz M
    Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of upper-limb spasticity after stroke: A clinical and neurophysiologic study.
    Pizzi A; Carlucci G; Falsini C; Verdesca S; Grippo A
    Arch Phys Med Rehabil; 2005 Mar; 86(3):410-5. PubMed ID: 15759220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the agreement between clinical, biomechanical and neurophysiological measures of spasticity.
    Malhotra S; Cousins E; Ward A; Day C; Jones P; Roffe C; Pandyan A
    Clin Rehabil; 2008 Dec; 22(12):1105-15. PubMed ID: 19052249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location and severity of spasticity in the first 1-2 weeks and at 3 and 18 months after stroke.
    Welmer AK; Widén Holmqvist L; Sommerfeld DK
    Eur J Neurol; 2010 May; 17(5):720-5. PubMed ID: 20050897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prediction of long-term upper limb spasticity after stroke: part of the SALGOT study.
    Opheim A; Danielsson A; Alt Murphy M; Persson HC; Sunnerhagen KS
    Neurology; 2015 Sep; 85(10):873-80. PubMed ID: 26276377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The construct validity of a spasticity measurement device for clinical practice: an alternative to the Ashworth scales.
    Pandyan AD; Van Wijck FM; Stark S; Vuadens P; Johnson GR; Barnes MP
    Disabil Rehabil; 2006 May; 28(9):579-85. PubMed ID: 16690587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.